ArticleJournal of experimental & clinical cancer research : CR2024

Correction: VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody.

Laura Micheli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.